Signaling Pathways
Signaling Pathways(信号通路)
- Proteases(63)
- Apoptosis(1190)
- Chromatin/Epigenetics(17)
- Metabolism(420)
- MAPK Signaling(32)
- Tyrosine Kinase(97)
- DNA Damage/DNA Repair(62)
- PI3K/Akt/mTOR Signaling(56)
- Microbiology & Virology(68)
- Cell Cycle/Checkpoint(205)
- Ubiquitination/ Proteasome(43)
- JAK/STAT Signaling(13)
- TGF-β / Smad Signaling(30)
- Angiogenesis(85)
- GPCR/G protein(3)
- Stem Cell(27)
- Membrane Transporter/Ion Channel(273)
- Cancer Biology(514)
- Endocrinology and Hormones(168)
- Neuroscience(462)
- Obesity, Appetite Control & Diabetes(9)
- Peptide Inhibitors and Substrate(1)
- Other Signal Transduction(141)
- Immunology/Inflammation(1111)
- Cardiovascular(63)
- Vitamin D Related
- Antibody-drug Conjugate/ADC Related
- PROTAC(254)
- Ox Stress Reagents(25)
- Others(1718)
- Antiparasitics(21)
- Toxins(90)
Signaling Pathways 相关产品(35130)
- GC13882Ranolazine 2HClCAS: 95635-56-6纯度: >99.50%
A piperazine derivative with cardioprotective activity
- GC13888Benidipine HClCAS: 91599-74-5纯度: >99.50% / >98.00%
An L-, T-, and N-type calcium channel blocker
- GC13906Nebivolol hydrochlorideCAS: 152520-56-4纯度: >99.50% / >98.00%
Nebivolol hydrochloride是第三代β1肾上腺素受体选择性拮抗剂,Nebivolol hydrochloride通过高选择性阻断β1受体并激活一氧化氮(NO)介导的血管扩张双重机制发挥降压作用,同时对外周血管阻力、代谢及性功能影响。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC13882 | Ranolazine 2HCl | 95635-56-6 | >99.50% | |
A piperazine derivative with cardioprotective activity | ||||
| GC13888 | Benidipine HCl | 91599-74-5 | >99.50% / >98.00% | |
An L-, T-, and N-type calcium channel blocker | ||||
| GC13891 | Tedizolid | 856866-72-3 | >98.00% | |
Tedizolid是一种恶唑烷酮类抗菌剂,对MSSA、MRSA、VRE.faecium和VRE.faecalis的MIC 50 值为0.5μg/ml,对MSSE、MRSE、PSSP和PRSP的MIC 50 值为0.25μg/ml。 | ||||
| GC13892 | C527 | 192718-06-2 | >99.50% | |
An inhibitor of the USP1/UAF complex | ||||
| GC13896 | NCX 466 | 1262956-64-8 | - | |
cyclooxygenase (COX)-inhibiting nitric oxide (NO) donor | ||||
| GC13897 | Homatropine Bromide | 51-56-9 | >99.50% | |
An anticholinergic agent | ||||
| GC13903 | Ro3280 | 1062243-51-9 | >99.00% | |
A selective Plk1 inhibitor | ||||
| GC13904 | SD-208 | 627536-09-8 | >99.00% | |
A potent, selective inhibitor of TGF-βRI | ||||
| GC13906 | Nebivolol hydrochloride | 152520-56-4 | >99.50% / >98.00% | |
Nebivolol hydrochloride是第三代β1肾上腺素受体选择性拮抗剂,Nebivolol hydrochloride通过高选择性阻断β1受体并激活一氧化氮(NO)介导的血管扩张双重机制发挥降压作用,同时对外周血管阻力、代谢及性功能影响。 | ||||
| GC13911 | S1RA hydrochloride | 1265917-14-3 | >99.00% | |
A σ 1 receptor antagonist | ||||
| GC13912 | NLG919 | 1402836-58-1 | >99.50% | |
An IDO pathway inhibitor | ||||
| GC13914 | Flumatinib mesylate | 895519-91-2 | >99.50% | |
A Bcr-Abl inhibitor | ||||
| GC13927 | A 77-01 | 607737-87-1 | >99.50% | |
A potent ALK5 inhibitor | ||||
| GC13932 | Dorzolamide | 120279-96-1 | - | |
An Analytical Reference Standard | ||||
| GC13946 | SNX-2112 | 908112-43-6 | - | |
SNX-2112是一种强效的合成型热休克蛋白(Hsp 90)抑制剂,IC 50 值为30nM。 | ||||
| GC13950 | TC-DAPK 6 | 315694-89-4 | - | |
TC-DAPK 6 是一种有效的、ATP 竞争性的、高度选择性的 DAPK 抑制剂(对 DAPK1 和 DAPK3 的 IC50 分别为 69 和 225 nM,ATP 浓度为 10 μM)。 | ||||
| GC13962 | VU 0361737 | 1161205-04-4 | >99.50% | |
A selective positive allosteric modulator of mGluR4 | ||||
| GC13966 | CS 2100 | 913827-99-3 | - | |
CS 2100 (Compound 10b) 是一种有效的、选择性的、口服活性的和 S1P3 保留的 S1P1 激动剂,对人 S1P1 的 EC50 为 4.0 nM。 | ||||
| GC13969 | GW9662 | 22978-25-2 | >99.50% / >98.00% | |
GW9662是一种特异性的过氧化物酶体增殖物激活受体-γ(PPAR-γ)抑制剂,其IC50为3.3 nM。 | ||||
| GC13971 | Cyproterone Acetate | 427-51-0 | >99.50% / >98.00% | |
An androgen receptor antagonist | ||||
| GC13974 | Salbutamol Sulfate | 51022-70-9 | >98.00% | |
A β 2 -AR agonist | ||||
| GC13976 | Doxapram hydrochloride hydrate | 7081-53-0 | >99.50% | |
A central respiratory stimulant | ||||
| GC13979 | Arbidol HCl | 131707-23-8 | >99.50% | |
A broad-spectrum antiviral agent | ||||
| GC13993 | Terazosin HCl | 70024-40-7 | >99.50% | |
A potent and selective α 1 -AR antagonist | ||||
